The stock price for Cue Biopharma Inc (CUE) currently stands at $0.86. The stock experienced a substantial increase in the last session, hitting $6.0 after starting at $0.86. The stock’s lowest price was $2.0 before closing at $0.7.
The market performance of Cue Biopharma Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $1.99 on 11/11/24, while the lowest value for the same duration was $0.45 on 09/26/24.
52-week price history of CUE Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Cue Biopharma Inc’s current trading price is -56.97% away from its 52-week high, while its distance from the 52-week low is 90.22%. The stock’s price range during the 52-week period has remained between $0.45 and $1.99. In the Healthcare sector, the company’s shares saw a trading volume of around 6.25 million for the day, which was evidently higher than the average daily volume of 0.21 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Cue Biopharma Inc (CUE) has experienced a quarterly rise of 8.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 64.49M and boasts a workforce of 41 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8125, with a change in price of -0.5140. Similarly, Cue Biopharma Inc recorded 262,680 in trading volume during the last 100 days, posting a change of -37.52%.
Examining CUE’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CUE stands at 1.08. Similarly, the long-term debt-to-equity ratio is also 0.03.
CUE Stock Stochastic Average
Cue Biopharma Inc’s raw stochastic average for the past 50 days is presently 64.45%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 64.45%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 60.94% and 64.78%, respectively.
CUE Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. This year’s metric has recorded a Price decrease of -8.96%. However, over the past six months, we’ve seen a stronger performance of -36.12%. The price of CUE fallen by 42.19% over the last 30 days. And in the last five days, it has surged by 9.28%.
